Rezultati

eNauka >  Rezultati >  Effects of Trilaciclib on Chemotherapy-Induced Myelosuppression and Patient-Reported Outcomes in Patients with Extensive-Stage Small Cell Lung Cancer: Pooled Results from Three Phase II Randomized, Double-Blind, Placebo-Controlled Studies
Naziv: Effects of Trilaciclib on Chemotherapy-Induced Myelosuppression and Patient-Reported Outcomes in Patients with Extensive-Stage Small Cell Lung Cancer: Pooled Results from Three Phase II Randomized, Double-Blind, Placebo-Controlled Studies
Autori: Weiss, Jared; Goldschmidt, Jerome; Andric, Zoran G  ; Dragnev, Konstantin H; Gwaltney, Chad; Skaltsa, Konstantina; Pritchett, Yili; Antal, Joyce M; Morris, Shannon R; Daniel, Davey
Godina: 2021
Publikacija: CLINICAL LUNG CANCER
ISSN: 1525-7304 Clinical Lung Cancer Pretraži identifikator
Tip rezultata: Naučni članak
Kolacija: vol. 22 br. 5 str. 449-460
DOI: 10.1016/j.cllc.2021.03.010
WoS-ID: 000729299500009
Scopus-ID: 2-s2.0-85106205765
URI: https://enauka.gov.rs/handle/123456789/810568
Izvor metapodataka: (Preuzeto iz Nasi u WoS)
M-kategorija: 
21M21 - Vodeći međunarodni časopis kategorije M21

65
SCOPUSTM
19
OpenCitations
59
WEB OF SCIENCETM
Alt metrika
Dimensions
Unpaywall

Rezultati na eNauka su zaštićeni autorskim pravima i sva prava su zadržana, osim ako nije drugačije naznačeno.